Please assess the completion status of the following clinical trial:

Trial Title: Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. All patients must be female~2. Locally advanced breast cancers or primary breast cancers with concomitant gross metastatic disease are eligible; locally advanced cancers must be of clinical and/or radiologic size \> 4 cm and/or are deemed surgically inoperable.~3. Negative serum pregnancy test (beta-human chorionic gonadotropin \[b-HCG\]) within 7 days of starting study, if of childbearing potential~4. Kidney and liver function tests - all within 1.5 times of the institution's upper limit of normal~5. Performance status (World Health Organization \[WHO\] scale) \< 2 and life expectancy \> 6 months~6. Age \> 18 years old~7. No brain and/or leptomeningeal disease~8. No previous or current malignancies at other sites within the last 5 years, with the exception of adequately treated cone-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin.~Exclusion Criteria:~1. Pregnancy or unwillingness to use a reliable contraceptive method in women of child-bearing potential.~2. Severe underlying chronic illness or disease~3. Patients on other investigational drugs while on study will be excluded.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).